As of 2026-08-21, NewMarket Corporation (NEU) has a 3-month relative strength percentile of 87 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.4%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
NEU is held by 41 ETFs as of May 2026. Top owner: AVUV at 0.42% weight, $113M notional. Top 3 carry $160M.
Held by 144 ETFs · $1.2B across latest filings · largest weight 4.79% (FXZ).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.42% | $113M | +0.13 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.13% | $29M | +0.01 pp |
| VAWVanguard Materials ETF | 0.40% | $18M | +0.09 pp |
| FNDA | 0.18% | $16M | +0.05 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.11% | $16M | +0.02 pp |
| AVLVAvantis U.S. Large Cap Value ETF | 0.11% | $15M | — |
| IVOO | 0.17% | $10M | +0.03 pp |
| IVOG | 0.33% | $6M | +0.06 pp |
| APUE | 0.23% | $6M | +0.03 pp |
| AVUSAvantis U.S. Equity ETF | 0.04% | $5M | — |
Showing 10 of 41 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NEU Jan avg: 1.20% median: -0.10% win: 50% σ: 7.14% n: 4 2022-04-12 → 2026-07-31 | NEU Feb avg: 5.63% median: 7.09% win: 50% σ: 10.85% n: 4 2022-04-12 → 2026-07-31 | NEU Mar avg: 1.73% median: 0.87% win: 50% σ: 3.39% n: 4 2022-04-12 → 2026-07-31 | NEU Apr avg: 1.14% median: 5.41% win: 60% σ: 10.91% n: 5 2022-04-12 → 2026-07-31 | NEU May avg: 3.96% median: 1.55% win: 80% σ: 6.41% n: 5 2022-04-12 → 2026-07-31 | NEU Jun avg: 0.08% median: 2.28% win: 60% σ: 6.25% n: 5 2022-04-12 → 2026-07-31 | NEU Jul avg: 6.25% median: 7.45% win: 80% σ: 5.00% n: 5 2022-04-12 → 2026-07-31 | NEU Aug avg: 4.76% median: 3.14% win: 75% σ: 11.59% n: 4 2022-04-12 → 2026-07-31 (current) | NEU Sep avg: -0.51% median: -1.48% win: 50% σ: 3.90% n: 4 2022-04-12 → 2026-07-31 | NEU Oct avg: -1.26% median: -1.86% win: 50% σ: 5.98% n: 4 2022-04-12 → 2026-07-31 | NEU Nov avg: 3.73% median: 2.74% win: 75% σ: 4.57% n: 4 2022-04-12 → 2026-07-31 | NEU Dec avg: -2.41% median: -1.26% win: 25% σ: 5.42% n: 4 2022-04-12 → 2026-07-31 |